Loss of p16 in advanced stage epithelial ovarian cancer is associated with chemoresistant disease, suboptimal debulking and poor progression-free survival: A Gynecologic Oncology Group study.

Gynecologic Oncology ◽

Advanced Stage ◽

Oncology Group ◽

Free Survival ◽

Association between the N-terminally truncated (ΔN) p63α (ΔNp63α) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2009.07.035 ◽

2009 ◽

Vol 115 (3) ◽

pp. 424-429 ◽

Cited By ~ 3

Author(s):

Elizabeth L. Jewell ◽

Kathleen M. Darcy ◽

Alan Hutson ◽

Paula S. Lee ◽

Laura J. Havrilesky ◽

...

Keyword(s):

Ovarian Cancer ◽

Gynecologic Oncology ◽

Advanced Stage ◽

Oncology Group ◽

Vegf Expression ◽

Free Survival ◽

Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: A gynecologic oncology group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2012.01.008 ◽

2012 ◽

Vol 125 (2) ◽

pp. 421-426 ◽

Cited By ~ 32

Author(s):

Jennifer M. Rubatt ◽

Kathleen M. Darcy ◽

Chunqiao Tian ◽

Franco Muggia ◽

Rajiv Dhir ◽

...

Keyword(s):

Ovarian Cancer ◽

Clinical Outcomes ◽

Gynecologic Oncology ◽

Advanced Stage ◽

Oncology Group ◽

Oncology Group Study ◽

Pre Treatment ◽

Tumor Expression

Prognostic significance of ethnicity and age in advanced stage epithelial ovarian cancer: An NRG oncology/gynecologic oncology group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2021.11.013 ◽

2021 ◽

Author(s):

Nefertiti C. duPont ◽

Danielle Enserro ◽

Mark F. Brady ◽

Katherine Moxley ◽

Joan L. Walker ◽

...

Keyword(s):

Ovarian Cancer ◽

Gynecologic Oncology ◽

Prognostic Significance ◽

Advanced Stage ◽

Oncology Group ◽

Phase III Gynecologic Oncology Group Study of Advanced Ovarian Cancer: Bevacizumab Added to Initial Chemotherapy Extends Progression-Free Survival

Oncology Times ◽

10.1097/01.cot.0000387947.51553.29 ◽

2010 ◽

Vol 32 (Sup 1) ◽

pp. 17

Author(s):

&NA;

Keyword(s):

Ovarian Cancer ◽

Gynecologic Oncology ◽

Advanced Ovarian Cancer ◽

Phase Iii ◽

Oncology Group ◽

Free Survival ◽

Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2009.02.009 ◽

2009 ◽

Vol 113 (3) ◽

pp. 341-347 ◽

Cited By ~ 26

Author(s):

John Farley ◽

Sartoru Fuchiuji ◽

Kathleen M. Darcy ◽

Chunqiao Tian ◽

William J. Hoskins ◽

...

Keyword(s):

Overall Survival ◽

Gynecologic Oncology ◽

Advanced Stage ◽

Oncology Group ◽

Free Survival ◽

Oncology Group Study ◽

Ovarian Cancers ◽

Erbb2 Amplification

8021 The effect of anemia on the progression-free survival in epithelial ovarian cancer (stage II-IV) patients treated with paclitaxel-carboplatin combination therapy: a retrospective analysis of the JGOG3016 trial of the Japanese Gynecologic Oncology Group (JGOG3016-A)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71543-5 ◽

2009 ◽

Vol 7 (2) ◽

pp. 456

Author(s):

T. Sugiyama ◽

S. Kumagai ◽

T. Shouji ◽

H. Michimae ◽

N. Katsumata ◽

...

Keyword(s):

Ovarian Cancer ◽

Combination Therapy ◽

Retrospective Analysis ◽

Gynecologic Oncology ◽

Cancer Stage ◽

Oncology Group ◽

Free Survival

Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: A Gynecologic Oncology Group study

Yearbook of Oncology ◽

10.1016/s1040-1741(09)79368-6 ◽

2009 ◽

Vol 2009 ◽

pp. 41-42

Author(s):

J.T. Thigpen

Keyword(s):

Overall Survival ◽

Gynecologic Oncology ◽

Advanced Stage ◽

Oncology Group ◽

Free Survival ◽

Oncology Group Study ◽

Ovarian Cancers ◽

Erbb2 Amplification

Maspin expression in epithelial ovarian cancer and associations with poor prognosis: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2006.02.014 ◽

2006 ◽

Vol 101 (3) ◽

pp. 390-397 ◽

Cited By ~ 26

Author(s):

Angeles Alvarez Secord ◽

Paula S. Lee ◽

Kathleen M. Darcy ◽

Laura J. Havrilesky ◽

Lisa A. Grace ◽

...

Keyword(s):

Ovarian Cancer ◽

Poor Prognosis ◽

Gynecologic Oncology ◽

Oncology Group ◽

Oncology Group Study ◽

Maspin Expression

Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708)

BMC Cancer ◽

10.1186/s12885-019-5514-7 ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 4

Author(s):

Young Shin Chung ◽

Sang-Yoon Park ◽

Jung-Yun Lee ◽

Jeong-Yeol Park ◽

Jeong-Won Lee ◽

...

Keyword(s):

Ovarian Cancer ◽

Neoadjuvant Chemotherapy ◽

Gynecologic Oncology ◽

Serous Carcinoma ◽

High Grade ◽

Advanced Stage ◽

Oncology Group ◽

An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2004.05.033 ◽

2004 ◽

Vol 94 (2) ◽

pp. 368-374 ◽

Cited By ~ 40

Author(s):

David H Moore ◽

James T Kauderer ◽

Jeffrey Bell ◽

John P Curtin ◽

Linda Van Le

Keyword(s):

Ovarian Cancer ◽

Gynecologic Oncology ◽

Oncology Group ◽

Alternative Treatments ◽

Oncology Group Study ◽

Factors Influencing